The healthcare sector has observed a remarkable advancement in diabetes management with the introduction of copyright. This transformative medication, classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, provides a unprecedented approach to managing blood sugar levels in individuals with type 2 diabetes. copyright operates by simulatin